Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes

Autor Peleg Hasson, Shira, Menes, Tehillah, Sonnenblick, Amir
Vydáno v Pharmgenomics Pers Med (2020)

Rates of atypical ductal hyperplasia have declined with less use of post-menopausal hormone treatment. Findings from the Breast Cancer Surveillance Consortium

Autor Menes, Tehillah S., Kerlikowske, Karla, Jaffer, Shabnam, Seger, Deborah, Miglioretti, Diana L.
Vydáno 2009

Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium

Autor Menes, Tehillah S., Rosenberg, Robert, Balch, Steven, Jaffer, Shabnam, Kerlikowske, Karla, Miglioretti, Diana L.
Vydáno 2013

Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy

Autor Menes, Tehillah S, Kerlikowske, Karla, Lange, Jane, Jaffer, Shabnam, Rosenberg, Robert, Miglioretti, Diana L.
Vydáno v JAMA Oncol (2017)

Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry

Autor Menes, Tehillah S., Terry, Mary Beth, Goldgar, David, Andrulis, Irene L., Knight, Julia A., John, Esther M., Liao, Yuyan, Southey, Melissa, Miron, Alexander, Chung, Wendy, Buys, Saundra S.
Vydáno v Breast Cancer Res Treat (2015)

Do Community-Based Patient Assistance Programs Affect the Treatment and Well-Being of Patients With Breast Cancer?

Autor Bickell, Nina A., Geduld, Andrea N., Joseph, Kathie-Ann, Sparano, Joseph A., Kemeny, M. Margaret, Oluwole, Soji, Menes, Tehillah, Srinivasan, Anitha, Franco, Rebeca, Fei, Kezhen, Leventhal, Howard
Vydáno v J Oncol Pract (2014)